{"entity":{"type":"insider","cik":"0001789815","url":"/insider/0001789815","json_url":"/insider/0001789815.json","name":"Tatsis Ourania","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":93,"n_filings":39,"first":"2019-10-03","last":"2026-07-07","span_basis":"filed_date"},"name_variants":[{"name":"Tatsis Ourania","source":"filing","n_filings":39,"first_seen":"2019-10-03","last_seen":"2026-07-07"}],"transactions":[{"id":6216273,"accession":"0000875320-26-000245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000245","line_url":"/filing/0000875320-26-000245#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":524.99,"price_display":"524.99","price_state":"stated","total_value":787485.0,"total_display":"787,485.00","total_whole":"787,485","shares_owned_after":45321.0,"shares_owned_after_display":"45,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-02","filed_date":"2026-07-07","scope":"insider"},{"id":6029070,"accession":"0000875320-26-000120","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000120","line_url":"/filing/0000875320-26-000120#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260.0,"shares_display":"260","price_per_share":486.35,"price_display":"486.35","price_state":"stated","total_value":126451.0,"total_display":"126,451.00","total_whole":"126,451","shares_owned_after":46763.0,"shares_owned_after_display":"46,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":5760992,"accession":"0000875320-26-000098","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000875320-26-000098","line_url":"/filing/0000875320-26-000098#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":368.0,"shares_display":"368","price_per_share":473.68,"price_display":"473.68","price_state":"stated","total_value":174314.24,"total_display":"174,314.24","total_whole":"174,314","shares_owned_after":48650.0,"shares_owned_after_display":"48,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-19","scope":"insider"},{"id":5760991,"accession":"0000875320-26-000098","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000875320-26-000098","line_url":"/filing/0000875320-26-000098#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":609.0,"shares_display":"609","price_per_share":489.46,"price_display":"489.46","price_state":"stated","total_value":298081.14,"total_display":"298,081.14","total_whole":"298,081","shares_owned_after":49018.0,"shares_owned_after_display":"49,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider"},{"id":6029057,"accession":"0000875320-26-000076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000076","line_url":"/filing/0000875320-26-000076#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":499.99,"price_display":"499.99","price_state":"stated","total_value":749985.0,"total_display":"749,985.00","total_whole":"749,985","shares_owned_after":46132.0,"shares_owned_after_display":"46,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-18","scope":"insider"},{"id":5891563,"accession":"0000875320-26-000052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000052","line_url":"/filing/0000875320-26-000052#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":466.0,"shares_display":"466","price_per_share":460.43,"price_display":"460.43","price_state":"stated","total_value":214560.38,"total_display":"214,560.38","total_whole":"214,560","shares_owned_after":51436.0,"shares_owned_after_display":"51,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider"},{"id":5926746,"accession":"0000875320-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000004","line_url":"/filing/0000875320-26-000004#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":474.99,"price_display":"474.99","price_state":"stated","total_value":2137455.0,"total_display":"2,137,455.00","total_whole":"2,137,455","shares_owned_after":42293.0,"shares_owned_after_display":"42,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-09","scope":"insider"},{"id":4903623,"accession":"0000875320-25-000244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000244","line_url":"/filing/0000875320-25-000244#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":449.99,"price_display":"449.99","price_state":"stated","total_value":2024955.0,"total_display":"2,024,955.00","total_whole":"2,024,955","shares_owned_after":46793.0,"shares_owned_after_display":"46,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-05","scope":"insider"},{"id":4977325,"accession":"0000875320-25-000146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000146","line_url":"/filing/0000875320-25-000146#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3242.0,"shares_display":"3,242","price_per_share":499.99,"price_display":"499.99","price_state":"stated","total_value":1620967.58,"total_display":"1,620,967.58","total_whole":"1,620,968","shares_owned_after":51239.0,"shares_owned_after_display":"51,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4261190,"accession":"0000875320-25-000141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000141","line_url":"/filing/0000875320-25-000141#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4058.0,"shares_display":"4,058","price_per_share":485.49,"price_display":"485.49","price_state":"stated","total_value":1970118.42,"total_display":"1,970,118.42","total_whole":"1,970,118","shares_owned_after":54481.0,"shares_owned_after_display":"54,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":4656532,"accession":"0000875320-25-000135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000135","line_url":"/filing/0000875320-25-000135#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":530.0,"shares_display":"530","price_per_share":475.34,"price_display":"475.34","price_state":"stated","total_value":251930.2,"total_display":"251,930.20","total_whole":"251,930","shares_owned_after":58539.0,"shares_owned_after_display":"58,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-28","scope":"insider"},{"id":4788437,"accession":"0000875320-25-000115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000115","line_url":"/filing/0000875320-25-000115#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":354.0,"shares_display":"354","price_per_share":480.95,"price_display":"480.95","price_state":"stated","total_value":170256.3,"total_display":"170,256.30","total_whole":"170,256","shares_owned_after":64031.0,"shares_owned_after_display":"64,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-26","scope":"insider"},{"id":4026583,"accession":"0000875320-25-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000095","line_url":"/filing/0000875320-25-000095#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":244.0,"shares_display":"244","price_per_share":455.06,"price_display":"455.06","price_state":"stated","total_value":111034.64,"total_display":"111,034.64","total_whole":"111,035","shares_owned_after":67695.0,"shares_owned_after_display":"67,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":4572946,"accession":"0000875320-25-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000048","line_url":"/filing/0000875320-25-000048#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":310.0,"shares_display":"310","price_per_share":459.83,"price_display":"459.83","price_state":"stated","total_value":142547.3,"total_display":"142,547.30","total_whole":"142,547","shares_owned_after":64021.0,"shares_owned_after_display":"64,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-12","scope":"insider"},{"id":2200510,"accession":"0000875320-24-000168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000168","line_url":"/filing/0000875320-24-000168#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2175.0,"shares_display":"2,175","price_per_share":460.0,"price_display":"460.00","price_state":"stated","total_value":1000500.0,"total_display":"1,000,500.00","total_whole":"1,000,500","shares_owned_after":49098.0,"shares_owned_after_display":"49,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2620796,"accession":"0000875320-24-000166","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000166","line_url":"/filing/0000875320-24-000166#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":445.0,"price_display":"445.00","price_state":"stated","total_value":1001250.0,"total_display":"1,001,250.00","total_whole":"1,001,250","shares_owned_after":51273.0,"shares_owned_after_display":"51,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-03","scope":"insider"},{"id":2620791,"accession":"0000875320-24-000166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000166","line_url":"/filing/0000875320-24-000166#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2350.0,"shares_display":"2,350","price_per_share":439.11,"price_display":"439.11","price_state":"stated","total_value":1031908.5,"total_display":"1,031,908.50","total_whole":"1,031,909","shares_owned_after":53523.0,"shares_owned_after_display":"53,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-06-03","scope":"insider"},{"id":2137781,"accession":"0000875320-24-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000109","line_url":"/filing/0000875320-24-000109#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":354.0,"shares_display":"354","price_per_share":425.7,"price_display":"425.70","price_state":"stated","total_value":150697.8,"total_display":"150,697.80","total_whole":"150,698","shares_owned_after":55804.0,"shares_owned_after_display":"55,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":3066996,"accession":"0000875320-24-000093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000093","line_url":"/filing/0000875320-24-000093#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":360.0,"shares_display":"360","price_per_share":421.77,"price_display":"421.77","price_state":"stated","total_value":151837.2,"total_display":"151,837.20","total_whole":"151,837","shares_owned_after":59467.0,"shares_owned_after_display":"59,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-23","scope":"insider"},{"id":2763579,"accession":"0000875320-24-000080","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000875320-24-000080","line_url":"/filing/0000875320-24-000080#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":480.0,"shares_display":"480","price_per_share":420.79,"price_display":"420.79","price_state":"stated","total_value":201979.2,"total_display":"201,979.20","total_whole":"201,979","shares_owned_after":59827.0,"shares_owned_after_display":"59,827","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider"},{"id":2034983,"accession":"0000875320-24-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000055","line_url":"/filing/0000875320-24-000055#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":314.0,"shares_display":"314","price_per_share":420.24,"price_display":"420.24","price_state":"stated","total_value":131955.36,"total_display":"131,955.36","total_whole":"131,955","shares_owned_after":68179.0,"shares_owned_after_display":"68,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":7973304,"accession":"0001209191-23-047309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047309","line_url":"/filing/0001209191-23-047309#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":355.0,"price_display":"355.00","price_state":"stated","total_value":887500.0,"total_display":"887,500.00","total_whole":"887,500","shares_owned_after":48637.0,"shares_owned_after_display":"48,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-23","filed_date":"2023-08-25","scope":"insider"},{"id":8309827,"accession":"0000899243-23-018112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-018112","line_url":"/filing/0000899243-23-018112#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5750.0,"shares_display":"5,750","price_per_share":345.79,"price_display":"345.79","price_state":"stated","total_value":1988292.5,"total_display":"1,988,292.50","total_whole":"1,988,293","shares_owned_after":51137.0,"shares_owned_after_display":"51,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-14","scope":"insider"},{"id":8364141,"accession":"0001209191-23-013765","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-013765","line_url":"/filing/0001209191-23-013765","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":354.0,"shares_display":"354","price_per_share":287.4808757062147,"price_display":"287.48","price_state":"stated","total_value":101768.23,"total_display":"101,768.23","total_whole":"101,768","shares_owned_after":56876.0,"shares_owned_after_display":"56,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-02-28","scope":"insider","n_lines":3},{"id":7994568,"accession":"0001209191-23-011704","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-011704","line_url":"/filing/0001209191-23-011704","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":480.0,"shares_display":"480","price_per_share":293.75329166666666,"price_display":"293.75","price_state":"stated","total_value":141001.58,"total_display":"141,001.58","total_whole":"141,002","shares_owned_after":60591.0,"shares_owned_after_display":"60,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-22","scope":"insider","n_lines":4},{"id":8436352,"accession":"0001209191-23-010061","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-010061","line_url":"/filing/0001209191-23-010061","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":320.0,"shares_display":"320","price_per_share":298.52034375,"price_display":"298.52","price_state":"stated","total_value":95526.51,"total_display":"95,526.51","total_whole":"95,527","shares_owned_after":65496.0,"shares_owned_after_display":"65,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-16","scope":"insider","n_lines":5},{"id":8151523,"accession":"0001209191-23-009237","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-009237","line_url":"/filing/0001209191-23-009237","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275.0,"shares_display":"275","price_per_share":298.99225454545456,"price_display":"298.99","price_state":"stated","total_value":82222.87,"total_display":"82,222.87","total_whole":"82,223","shares_owned_after":65840.0,"shares_owned_after_display":"65,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider","n_lines":5},{"id":6914764,"accession":"0000899243-22-028248","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-028248","line_url":"/filing/0000899243-22-028248","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":298.9691,"price_display":"298.97","price_state":"stated","total_value":418556.74,"total_display":"418,556.74","total_whole":"418,557","shares_owned_after":46519.0,"shares_owned_after_display":"46,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-10","scope":"insider","n_lines":5},{"id":6341448,"accession":"0000899243-22-011705","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-011705","line_url":"/filing/0000899243-22-011705","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2833.0,"shares_display":"2,833","price_per_share":250.11368160960112,"price_display":"250.11","price_state":"stated","total_value":708572.06,"total_display":"708,572.06","total_whole":"708,572","shares_owned_after":47390.0,"shares_owned_after_display":"47,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-21","scope":"insider","n_lines":2},{"id":6767238,"accession":"0000899243-22-008123","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-008123","line_url":"/filing/0000899243-22-008123#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115.0,"shares_display":"115","price_per_share":230.97,"price_display":"230.97","price_state":"stated","total_value":26561.55,"total_display":"26,561.55","total_whole":"26,562","shares_owned_after":50294.0,"shares_owned_after_display":"50,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-02-28","scope":"insider"},{"id":6767235,"accession":"0000899243-22-008123","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-008123","line_url":"/filing/0000899243-22-008123#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87.0,"shares_display":"87","price_per_share":231.81,"price_display":"231.81","price_state":"stated","total_value":20167.47,"total_display":"20,167.47","total_whole":"20,167","shares_owned_after":50207.0,"shares_owned_after_display":"50,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-02-28","scope":"insider"},{"id":6767232,"accession":"0000899243-22-008123","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-008123","line_url":"/filing/0000899243-22-008123#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001789815","owner_name":"Tatsis Ourania","owner_display_name":"Tatsis Ourania","owner_url":"/insider/0001789815","role":"Officer (EVP, Chief Reg. & Quality Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. & Quality Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. & Quality Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77.0,"shares_display":"77","price_per_share":230.26,"price_display":"230.26","price_state":"stated","total_value":17730.02,"total_display":"17,730.02","total_whole":"17,730","shares_owned_after":50409.0,"shares_owned_after_display":"50,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-02-28","scope":"insider"}],"collapsed":true,"next_cursor":"2022-02-25|6767232","ledger_fault":false,"count":{"value":93,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":93,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":93},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP, Chief Reg. & Quality Off)","n_filings":39,"first_seen":"2019-10-03","last_seen":"2026-07-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001789815","retrieved_at":"2026-08-26T10:16:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}